Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Chen-Yue Qian"'
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-7 (2017)
Abstract Background Chemotherapy toxicity is a serious problem from which non-small cell lung cancer (NSCLC) patients suffer. The mismatch repair (MMR) system is associated with platinum-based chemotherapy toxicity in NSCLC patients. In this study, w
Externí odkaz:
https://doaj.org/article/6e8adb01991f4c14975f774db63047be
Autor:
Chen-Yue Qian, Yi Zheng, Ying Wang, Juan Chen, Jun-Yan Liu, Hong-Hao Zhou, Ji-Ye Yin, Zhao-Qian Liu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-13 (2016)
Abstract Background Platinum-based chemotherapy is the first-line treatment of non-small cell lung cancer (NSCLC); it is therefore important to discover biomarkers that can be used to predict the efficacy and toxicity of this treatment. Four importan
Externí odkaz:
https://doaj.org/article/3f4f1b254a2d4e9fa3c22ddbd6ebc2f1
Autor:
Ying Wang, Ji-Ye Yin, Xiang-Ping Li, Juan Chen, Chen-Yue Qian, Yi Zheng, Yi-Lan Fu, Zi-Yu Chen, Hong-Hao Zhou, Zhao-Qian Liu
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91967 (2014)
Lung cancer is one of the most common cancers and is the leading cause of death worldwide. Platinum-based chemotherapy is the main treatment method in lung cancer patients. Our previous studies indicated that single nucleotide polymorphisms (SNPs) in
Externí odkaz:
https://doaj.org/article/ca03f0fe10a94f998afb1b0eaa7a977f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-7 (2017)
Chinese Journal of Cancer
Chinese Journal of Cancer
Background Chemotherapy toxicity is a serious problem from which non-small cell lung cancer (NSCLC) patients suffer. The mismatch repair (MMR) system is associated with platinum-based chemotherapy toxicity in NSCLC patients. In this study, we aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186af7f8ea2f988ed42269f07b3b66bf
http://link.springer.com/article/10.1186/s40880-016-0175-2
http://link.springer.com/article/10.1186/s40880-016-0175-2
Autor:
Ji-Ye Yin, Juan Chen, Yi Zheng, Hong-Hao Zhou, Zhao-Qian Liu, Ying Wang, Chen-Yue Qian, Jun-Yan Liu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-13 (2016)
Chinese Journal of Cancer
Chinese Journal of Cancer
Platinum-based chemotherapy is the first-line treatment of non-small cell lung cancer (NSCLC); it is therefore important to discover biomarkers that can be used to predict the efficacy and toxicity of this treatment. Four important transporter genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e246590d84ef34a83de130e76095153
http://link.springer.com/article/10.1186/s40880-016-0145-8
http://link.springer.com/article/10.1186/s40880-016-0145-8
Autor:
Lin Wu, Wei Zhang, Juan Chen, Zhan Wang, Hong-Hao Zhou, Hui-Hua Li, Ting Zou, Chen-Yue Qian, Chuntian Li, Zhao-Qian Liu, Ying Wang, Ji-Ye Yin, Xiang-Ping Li
Publikováno v:
Tumor Biology. 37:2275-2284
Lung cancer is the first leading cause of cancer deaths. Chemotherapy toxicity is one of factors that limited the efficacy of platinum-based chemotherapy in lung cancer patients. Transporters and DNA repair genes play critical roles in occurrence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3adb773abd991e7c0df8a70e06b502
https://doi.org/10.1007/s13277-015-4048-0
https://doi.org/10.1007/s13277-015-4048-0
Autor:
Shu-Fen Zhang, Hong-Hao Zhou, Cai-Yi Zhang, Ji-Ye Yin, Zhao-Qian Liu, Lanqin Cao, Jingjing Yu, Yu Zhang, Zheng-Zheng Li, Yan Tian, Yi Zhang, Wei Zhang, Chen-Yue Qian
Publikováno v:
Oncotarget
// Yu Zhang 1, 3 , Jing-Jing Yu 3 , Yan Tian 3 , Zheng-Zheng Li 3 , Cai-Yi Zhang 3 , Shu-Fen Zhang 3 , Lan-Qin Cao 3 , Yi Zhang 3 , Chen-Yue Qian 1, 2 , Wei Zhang 1, 2 , Hong-Hao Zhou 1, 2 , Ji-Ye Yin 1, 2 , Zhao-Qian Liu 1, 2 1 Department of Clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3685893ef823bdcb54cabe83bfbf597c
https://doi.org/10.18632/oncotarget.4555
https://doi.org/10.18632/oncotarget.4555
Autor:
Hong-Hao Zhou, Juan Chen, Chen-Yue Qian, Zhao-Qian Liu, Rong Liu, Xiang-Ping Li, Ji-Ye Yin, Xiang-Guang Meng, Yi Zheng
Publikováno v:
Acta Pharmacologica Sinica. 36:375-384
Eukaryotic translation initiation factor 3 subunit A (eIF3a) plays critical roles in regulating the initiation of protein translation, and eIF3a is highly expressed in lung cancer. In this study, we investigated the association of the positively sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f783658dc335bb8bde2447e5cbea73cc
https://doi.org/10.1038/aps.2014.160
https://doi.org/10.1038/aps.2014.160